Mucosal-associated invariant T (MAIT) cells are innate-like T lymphocytes with potent antibacterial reactivity. In this study, we investigated whether MAIT cells also contribute to immunity against influenza A viruses. Compared with those who succumbed, hospitalized patients who recovered from severe avian H7N9 influenza infection had higher numbers of MAIT cells. Subsequent in vitro analysis established that MAIT cells from healthy donors are indirectly activated by influenza infection via an IL-18-dependent (but not IL-12-dependent) mechanism requiring the involvement of CD14+ monocytes. Our findings highlight the potential for MAIT cells to promote protective immunity in human influenza
an indirect, IL-18-dependent mechanism indicates that MAIT cells are protective in influenza, and also possibly in any human disease process in which inflammation and IL-18 production occur.
Human mucosal associated invariant T (MAIT) cells are innate-like T lymphocytes characterized by a
semi-invariant T-cell receptor (TCR), Vα7.2 (TRAV 1-2), paired with variable β-chains (1, 2) . In adult blood, MAIT cells are further defined by constitutive, high-level expression of the IL-18 receptor (IL-18R), the promyelocytic leukemia zinc finger (PLZF) transcription factor, and the CD161 C-type lectin (3, 4) . Potently reactive to metabolites of vitamin B2 biosynthetic intermediates (5, 6 ) that bind to the non-classical MHC-1-related (MR1) proteins, MAIT cells are robustly activated to produce cytokines and chemokines [IFNγ, TNF, granzyme B (GzmB), IL-17A, and IL -22] following exposure to microbes (Salmonella, Escherichia coli, and Candida albicans) that possess riboflavin pathways (4, 7) . Given the prominence of MAIT cells in human peripheral blood (1-10%) and in tissue sites of inflammation, including the gut and lung (3, 8, 9) , there is a need to define their role in immunity, with the situation for viral infections remaining relatively unclear.
During HIV-1 infection, numbers of MAIT cells, as defined by coexpression of CD161 and Vα7.2, are reduced (10⇓-12), and their numbers in the periphery are not restored after antiretroviral drug treatment, although it is thought that microbial translocation may drive chronic MAIT cell activation (10, 11) . Moreover, with the advent of MR1 tetramers to detect MAIT cells, more recent studies have confirmed the loss of MAIT during chronic HIV infection (1, 12) . To date, only murine studies in Vα19Vβ6 transgenics have demonstrated that MAIT cells, as measured by CD69 up-regulation in vitro, are not activated by coculture with antigen-presenting cells infected with a range of viruses, including Sendai virus, Newcastle disease virus, and herpes simplex virus (8) . Stimulation with IL-12 and IL-18 can, however, induce IFNγ production in human MAIT cells in an MR1-independent manner (13, 14) .
Because MAIT cells are both pro-inflammatory and potentially activated by IL-12 and IL-18, the possibility that they play a positive role in respiratory virus infections seems plausible. In a recent report of a hospitalized patient cohort, we established that a spectrum of innate and antigen-specific responder cells is recruited during the course of severe H7N9 influenza pneumonia (15) . Our further analysis from this study of the CD161+Vα7.2+ MAIT cells recovered ex vivo from these patients showed that the numbers were 2.5-fold greater in those who survived, suggesting that MAIT cells may indeed contribute to protection. 
RESULTS

Reduced Numbers of MAIT Cells in Fatal Influenza.
We recently investigated the population dynamics of CD8+ T-cell responses in hospitalized H7N9 patients with severe influenza pneumonia (15) . Given that the CD8+ Vα7.2+ subset is likely to include both MR1-restricted and -non-restricted MAIT cells (1), we performed a retrospective comprehensive analyses using CD161 in combination with TCR Vα7.2 to determine whether the MAIT cell response varies in hospitalized patients with different clinical outcomes. Comparing the numbers of CD161+Vα7.2+ T cells in stored PBMCs between patients who recovered and those with a fatal outcome across all available time points after disease onset (n = 16 patients; days revealed significantly lower numbers of MAIT cells in the fatal cases (P = 0.014, nonparametric oneway ANOVA) (Fig. 1A) . However, the comparable peripheral blood counts for CD161+Vα7.2+ MAIT cells in the survivors (mean age, 68 y) and in healthy controls (mean age, 70 y) indicates that MAIT cell activation may be markedly reduced in fatal influenza infection. Another possibility is that the MAIT cells are recruited to, and perhaps destroyed at, the site of pathology.
To gain insight into the dynamics of MAIT cell involvement during the course of severe influenza disease, we analyzed CD161+Vα7.2+ T cells at multiple time points after disease onset: days 6-12, days 13-20, and days [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] (Fig. 1B) . As in our previous study (15) , we subdivided patients hospitalized at ∼days 6-8 after the onset of symptoms according to their recovery rates, ranging from early (R1: days 14-18 after disease onset) to delayed (R2: days 21-27, R3: days 31-35), vs. a fatal outcome. Our data show that during the first week of hospitalization (days [6] [7] [8] [9] [10] [11] [12] , only the patients who recovered early from H7N9 disease (R1) had higher MAIT cell numbers than seen in the fatal group (P < 0.05) (Fig. 1 B, i and C) . Interestingly, there was a trend (albeit insignificant) toward higher numbers of MAIT cells in delayed recovery group R3 during the last week of hospitalization (days [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] (Fig. 1 B, iii) , which was not observed in group R2, which had a shorter hospital stay. Given the robust IFNγ production by MAIT, NK, and γδ T cells, we next evaluated for any correlation between the high frequency of MAIT cells producing IFNγ during influenza infection and IFNγ production in NK or γδ T cells within the same donor. Indeed, we observed strong correlations in IFNγ production between MAIT/NK (P < 0.01; r = 0.569, Spearman rank correlation) and MAIT/γδ T cells (P < 0.0001; r = 0.888) (Fig. S2) , suggesting that overall, these three subsets respond mutually during IAV infection. This does not imply that MAIT cells are dependent on NK or γδ T cells to produce IFNγ, however.
Coculture of PBMCs with IAV-infected A549 cells did not result in significant expression of CD107a
(minimally on NK cells), a known marker of degranulation for NK, MAIT, and γδ T cells (Fig. 2D ), or TNF production (Fig. S3) . However, the MAIT cells, and not the conventional CD8+/CD4+ T-cell subsets, up-regulated CD69 surface expression during coculture with IAV-infected A549 cells (Fig.   2F ). Significant up-regulation of intracellular GzmB was also observed (***P < 0.001; n = 12). We further suggest that GzmB is an early marker of MAIT cell activation (Fig. 2G) , and also that the surrogate MAIT cell markers CD161 and Vα7.2 identify the IFNγ-producing MR1-5-OP-RUTet+Vα7.2+ after early IAV infection (Fig. S4) .
MAIT Cell Activation Is Not Abrogated by MR1-Blocking Antibody.
To understand MAIT cell activation during IAV infection, we first asked whether MAIT cell IFNγ production after exposure to IAV-infected epithelial cells is MR1-dependent. Several riboflavin derivatives from microbial species, including Escherichia coli, are presented by MR1 (5, 6, 17, 18) ; however, the addition of α-MR1-blocking monoclonal antibody (clone 26.5) to the IAV coculture system did not reduce the relative expression levels of IFNγ compared with coculture of PBMCs with 1% paraformaldehyde-fixed E. coli, where α-MR1 is known to inhibit cytokine production in MAIT cells (by approximately twofold) (Fig. 3A) . This suggests that the activation of MAIT cells during
IAV coculture is MR1-independent
In the absence of other PBMC subsets, FACS-purified CD161+Vα7.2+CD3+ MAIT cells cultured with IAV-infected A549 cells for 10 h in the presence of BFA did not make IFNγ (Fig. 3B) . However, comparably enriched CD56+CD3− NK cells up-regulated IFNγ production above background (uninfected A549) during direct coculture with IAV-infected A549 cells (Fig. 3C) . Taken To understand whether MAIT cells are activated via the IAV-induced inflammatory milieu, we assayed for cytokines/chemokines in the culture supernatants by a cytometric bead array (CBA) analysis. After IAV infection, but in the absence of PBMCs, the A549 cells up-regulated chemotactic molecules for monocytes and lymphocytes, namely MCP-1 and RANTES (Fig. 3 D, i) . Elevated levels of IL-6, MCP-1, MIP1α/β, and IL-1β were observed during IAV infection, but these were present in uninfected controls as well (Fig. 3 D, ii) . Type I IFN (IFNα) production was, as might be expected, limited to the IAV-exposed cells. Moreover, when both IAV-infected A549 cells and PBMCs were present, TNF, IFNγ, and GzmB were detected early in the culture supernatants (Fig.   3 D, iii) .
To examine whether influenza-induced soluble mediators can directly activate MAIT cells to produce IFNγ, we transferred supernatants from uninfected and IAV-infected cocultures to autologous PBMCs and measured IFNγ responses in the various lymphocyte subsets by ICS (Fig. 4A) . We found that supernatants from uninfected A549-PBMC cocultures contained inflammatory mediators (Fig. 3D) that did not activate MAIT cells (Fig. 4 B, i, Middle) . In contrast, when the supernatants from the IAV cocultures were added to autologous PBMCs, they induced robust production of IFNγ in MAIT cells (Fig. 4 B, i and ii), although MAIT cell GzmB expression was affected variably (Fig. 4 B, ii) .
Conversely, the up-regulation of IFNγ in NK cells was significantly reduced when cocultured with the IAV supernatants, indicating that NK cells require both accessory cells and inflammatory mediators for optimal induction during IAV infection (Fig. 4 B, iii) . Taken together, these data suggest that MAIT cells are activated by soluble inflammatory mediator(s) induced during IAV infection.
IL-18-Dependent Activation of MAIT Cells During IAV Infection.
Earlier studies (14, 19) have shown that MAIT cells respond robustly to cytokine-driven stimulation (IL-18, IL-12, and IL-7) and constitutively express high surface levels of the IL-18 and IL-12 receptors (14) . Given our findings indicating that MAIT cells make IFNγ and GzmB when stimulated in IAV A549-PBMC cocultures (Fig. 4 A and B) , we assessed whether IL-12 and IL-18 are the soluble inflammatory mediators driving this process. Indeed, compared with other PBMC subsets, the MAIT cells expressed higher surface levels of the IL-18R (Fig. 4C ). Subsequent addition of both αIL-18 and αIL-12 to the IAV A549-PBMC cocultures led to an ∼50% reduction in IFNγ production (48.5 ± 12.5%; n = 4) by MAIT cells (Fig. 4D, second column) . This drop in IFNγ secretion is attributed to IL-18 rather than to IL-12 (Fig. 4D , third column; *P < 0.05), because robust IFNγ production was retained for cultures containing only the IL-12 p40/70 blocking antibody (Fig. 4D, fourth column) .
Even so, given that we did not observe a complete reduction in IFNγ production, our data suggest that in addition to IL-18, other inflammatory mediators also may contribute to the up-regulation of IFNγ production during early IAV infection.
CD14+ monocytes are required for MAIT cell activation during IAV coculture.
It is clear that IAV infection triggers the recruitment and differentiation of monocytes (Fig. 3D ) via chemotactic cytokines/chemokines (20) . Activated monocytes can then serve as a source of proinflammatory and antiviral mediators during IAV infection (reviewed in ref. 16 ). When CD14+ monocytes were cocultured with IAV-infected lung epithelial cells, we observed a significant increase in TNF production compared with that found after exposure to uninfected epithelial cells ( Fig. 5A ; **P < 0.002). This suggests that monocytes are directly activated by exposure to IAVinfected epithelium, and in turn contribute to the induction of MAIT cells during influenza.
To examine this possibility, we depleted the CD14+ monocytes (>99%) from PBMCs using magnetic beads. In the absence of the CD14+ sets, IFNγ production in MAIT cells was significantly, although not completely, reduced (Fig. 5 B, i and ii; **P < 0.01), although IFNγ in the NK cells was reduced to background levels ( Fig. 5 B, i) . This indicates that CD14+ monocytes contribute to the activation of MAIT cells during coculture, and may provide a source of IL-18 for activation.
Discussion
Influenza contributes significantly to morbidity and mortality in high-risk groups, including elderly persons, young children, pregnant women, and immunocompromised individuals (21, 22) . Although B cells producing strain-specific neutralizing antibodies are the gold standard of sterilizing immunity, they provide little or no protection against newly emerging pandemic IAV strains. Consequently, if we are to deal effectively with the threat posed by a novel IAV subtype (or some other emerging pathogen), we first need to understand the roles of other arms of innate and adaptive immunity, then investigate whether it is possible to manipulate such defense mechanisms. These potential mediators of "universal" immunity include nonneutralizing antibodies, cross-reactive IAV-specific T cells, neutrophils, macrophages, NK cells, and other "innate-like" T cells (23, 24) . Although it is well appreciated that classical innate cell types, such as neutrophils, macrophages, and dendritic cells, play essential roles in the influenza-specific host response (16) , there is a paucity of data on whether, and if so how, MAIT cells contribute to antiviral immunity during influenza and other viral infections.
The present study shows that in the absence of preexisting neutralizing antibodies, the absolute numbers of CD161+Vα7.2+ MAIT cells in H7N9-infected patients are higher in patients with severe but nonfatal influenza than in those who succumb to this disease. This situation is in contrast to chronic viral infections such as HIV, where an ongoing inflammatory process is not characterized by any recovery in MAIT cell numbers, even after effective antiretroviral therapy (10, 12) .
Having established a possible correlation with MAIT cell numbers in hospitalized patients with H7N9-induced IAV pneumonia of varying severity, we next asked how MAIT cells are activated during early influenza infection, using an in vitro model of IAV-infected human lung epithelial cells cocultured with PBMCs. Our findings led to the proposal that robust MAIT cell up-regulation of IFNγ and GzmB follows such IAV exposure and is dependent on soluble inflammatory mediators, particularly IL-18 (Fig. 5C) . Although previous studies with Vα19Vβ6-Tg mice indicated that a range of virus-infected (but not including IAV) macrophages failed to activate MAIT cells in vitro (7), we have shown that CD14+monocytes are required for the optimal induction of the MAIT cell response in IAV pneumonia. Furthermore, our findings suggest that GzmB is a useful ex vivo marker for MAIT cell activation during early IAV infection.
It is well established that T and NK cells make IFNγ when cultured in the presence of IL-18, a potent proinflammatory cytokine. Indeed, our data demonstrate that IFNγ production in NK cells is modulated in part by IL-18, although we suggest that additional cell-associated factors are needed for complete activation. The mechanisms leading to MAIT activation (IFNγ and GzmB up-regulation) are indirect, with the MAIT cells induced predominantly by soluble mediators produced during early IAV infection. Earlier work in human PBMCs has shown that IL-18, acting synergistically with IL-12, is important for the TLR-driven activation of MAIT cells (14, 25, 26) ; however, our present analysis demonstrates that blocking soluble IL-18 (but not IL-12 singly) abrogates IFNγ production during IAV infection. Similarly, previous studies using murine models of IAV infection have demonstrated that IL-18 alone is required for optimal IFNγ production in CD8+ T cells (27) . Although IL-12 was not detected in our CBA analyses, the physiological concentration may be below the limit of detection. Furthermore, Guo et al. (28) reported that IL-18 (but not IL-12) was readily found in the serum of hospitalized H7N9 patients. Indeed, the fact that IL-18 is present at significant levels in the peripheral circulation suggests that a "global" activation of MAIT cells may occur in multiple peripheral sites in addition to the infected lung.
Considering that complete abrogation of IFNγ production was not found consequent to IL-18 blocking, it is possible that other inflammatory mediators (e.g., MCP-1, TNF, type 1 IFN) in supernatants from the IAV-infected cocultures may further activate MAIT cells. These inflammatory mediators are characteristic of the "cytokine storm" that can be detected in both bronchiolar lavage fluid and serum from hospitalized H7N9 patients (20) . Given such potent hypercytokinemia, it could prove informative to look more closely at MAIT cells in severe, debilitating viral infections, both in patients and in animal models.
We speculate that monocytes are the source of IL-18 during in vitro coculture, given that depletion of this subset from the PBMC pool resulted in a significant abrogation in MAIT IFNγ up-regulation.
Recent studies showing TCR-independent MAIT cell induction for PBMCs cultured in vitro with IL-15 have demonstrated that this activation is dependent on the presence of IL-18-producing monocytes (25) . Previous studies also have suggested that live IAV infection can promote the differentiation of monocytes into dendritic cells (29, 30) . Thus, the cytokine/chemokine milieu generated during in vitro coculture may promote first monocyte differentiation, then MAIT cell activation during IAV infection. In addition, lung epithelial cells express the IL-18 precursor protein (31) 
